| 1st Apr 2026 7:00 am |
RNS |
ViiV completes changes to minority shareholding |
| 1st Apr 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 31st Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 30th Mar 2026 7:05 am |
RNS |
Bepirovirsen accepted for review in China |
| 30th Mar 2026 7:00 am |
RNS |
Exdensur approved for severe asthma in China |
| 30th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 27th Mar 2026 7:00 am |
RNS |
Bepirovirsen accepted for review by the EMA |
| 27th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 26th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 25th Mar 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 25th Mar 2026 1:00 pm |
RNS |
Notice of AGM |
| 25th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 24th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 23rd Mar 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Mar 2026 3:00 pm |
RNS |
Admission to Trading |
| 23rd Mar 2026 7:00 am |
RNS |
GSK Lung Cancer ADC Gets Japan Orphan Drug Status |
| 23rd Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 20th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 19th Mar 2026 12:00 pm |
RNS |
Lynavoy (linerixibat) approved by US FDA |
| 19th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 18th Mar 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 18th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 17th Mar 2026 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 17th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 17th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 13th Mar 2026 10:31 am |
RNS |
US FDA approves Arexvy for adults 18-49 AIR |
| 13th Mar 2026 10:31 am |
RNS |
US FDA approves Arexvy for adults 18-49 AIR |
| 13th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 13th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 12th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 11th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 11th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 10th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 9th Mar 2026 3:00 pm |
RNS |
Board Committee Change |
| 9th Mar 2026 3:00 pm |
RNS |
Board Committee Change |
| 9th Mar 2026 7:00 am |
RNS |
GSK and Alfasigma agree global linerixibat rights |
| 9th Mar 2026 7:00 am |
RNS |
Transaction in Own Shares |
| 6th Mar 2026 2:21 pm |
RNS |
Filing of GSK plc 2025 Annual Report on Form 20-F |
